CVS Health Corporation (NYSE:CVS) registered a -1.99% decrease, still its new closing price is 12.87% up from the company’s 1 year high of 105.04.It posted -4.67% losses in previous 5 sessions and is now the subject of 6 analysts who together assign a hold rating on stock. 0 of Wall Street analysts have an underperform rating; the 0 sells versus 10 buy or better ratings. The 25 stock analysts following this company have an average price target at $87.95, with individual PT in the $66.90-$114.00 range. The shares moved at $77.75, implying that brokerage firms see shares losing about -15.20% in twelve months time.

CVS Health Corporation (CVS) SEC Form 4 News

The stock is getting much attention these days as insiders are offloading shares while they posted a -0.87% fall year to date. A EVP & CIO at CVS Health Corporation (CVS) offloaded shares in a transaction closed on Thursday May 05, 2016. GOLD STEPHEN J sold 9,798 shares in the company at $105 each and collected $1,028,001 in proceeds. GOLD STEPHEN J now owns 7,093 shares in the company after this transaction. A EVP and Chief Medical Officer in the company, Brennan Troyen A, disclosed a transaction on Thursday May 05, 2016 that ended up generating $789,000 from the sale of 7,517 shares at $105 per share.

CVS Health Corporation (NYSE:CVS) Upcoming Results on Tap

CVS Health Corporation will next provide financial results for the March 2017 quarter. Stock analysts expect it to report per-share earnings of $1.33 in that period. Sales during the quarter are predicted to arrive at $45.16 billion.

Earnings surprise history: Last quarter, the company posted approximately $44.62 billion in revenue and EPS of $1.59. The mean forecast was for $45.29 billion and $1.57 a share, respectively. One quarter earlier, revenue for the stock was at $43.73 billion, with earnings at $1.32/share.

CVS Health Corporation (CVS) Brokerage Update

CVS Health Corporation (CVS) is in Jefferies’s research list so their analyst rating change is noteworthy. These shares were downgraded to Hold from Buy by Jefferies, according to news reported on Monday December 12, 2016.Another important research note was issued by Morgan Stanley on Monday June 20, 2016.The firm downgraded CVS to Equal-Weight from Overweight. Over the last six months and over the last three months, the shares of CVS Health Corporation (CVS), have changed -15.83% and -10.68%, respectively.